SUSQUEHANNA INTERNATIONAL GROUP, LLP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 32 filers reported holding REPROS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$61,000
-10.3%
91,976
-56.6%
0.00%
Q3 2017$68,000
-47.3%
212,100
-24.1%
0.00%
Q2 2017$129,000
-53.8%
279,500
+20.0%
0.00%
Q1 2017$279,000
-37.2%
232,900
-30.8%
0.00%
Q4 2016$444,000
-61.0%
336,327
-38.3%
0.00%
Q3 2016$1,139,000
+67.5%
545,100
+29.1%
0.00%
Q2 2016$680,000
+213.4%
422,100
+88.2%
0.00%
Q1 2016$217,000
-19.3%
224,300
+1.0%
0.00%
Q4 2015$269,000
-92.8%
222,123
-56.0%
0.00%
-100.0%
Q3 2015$3,750,000
+34.0%
504,675
+29.0%
0.00%0.0%
Q2 2015$2,798,000
-38.7%
391,362
-26.3%
0.00%0.0%
Q1 2015$4,562,000
+1.0%
531,073
+17.2%
0.00%
-50.0%
Q4 2014$4,516,000
-48.2%
452,996
-48.5%
0.00%
-33.3%
Q3 2014$8,714,000
+12.6%
880,247
+96.7%
0.00%0.0%
Q2 2014$7,741,000
-30.7%
447,509
-29.0%
0.00%
-40.0%
Q1 2014$11,177,000
+58.4%
630,071
+63.4%
0.01%
+66.7%
Q4 2013$7,055,000
-75.8%
385,500
-64.6%
0.00%
-81.2%
Q3 2013$29,158,000
+26.5%
1,087,935
-12.9%
0.02%
+23.1%
Q2 2013$23,048,0001,249,2100.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders